Date Name Title Filing Type Shares Traded Price Total Held
Jan 09, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 29 $17.52 4,072
Feb 27, 2020
EVP Research and Development
EVP Research and Development Form 4 Open market or private sale of non-derivative or derivative security 31 $468.56 11,380
Feb 13, 2020
EVP Research and Development
EVP Research and Development Form 4 Open market or private sale of non-derivative or derivative security 31 $406.44 11,380
Jan 09, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 43 $17.54 3,864
Jan 09, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 43 $17.60 3,127
Oct 31, 2006
SVP, Therap & Clin Prog Dev
SVP, Therap & Clin Prog Dev Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 48 $10.56 9,695
Oct 31, 2006
SVP, Therap & Clin Prog Dev
SVP, Therap & Clin Prog Dev Form 4 Open market or private sale of non-derivative or derivative security 48 $20.16 9,647
Oct 31, 2006
SVP, Therap & Clin Prog Dev
SVP, Therap & Clin Prog Dev Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 48 -- --
Jan 09, 2004
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 53 $15.26 15,673
Jan 09, 2004
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 53 $15.21 15,352

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.